Dr. Vikash Oza explores how to reframe adult dermatologic diagnoses like lipomas and cysts when evaluating rare presentations in pediatric patients. Topics Covered: Diagnosing adult-onset

Dr. Harper discusses working with a young man who showed improvement of acne of the mid-face with isotretinoin treatment, who eventually developed large fluctuant nodules

Dr. Culton discusses diagnosing non-blistering clinical phenotypes of pemphigoid and pemphigus and the increasingly common prevalence of drug-induced pemphigoid.

Dr. Zirwas discusses clinical impacts of notable additions to the dermatology literature this year—including 1% diclofenac gel for acne keloidalis nuchae and pseudofolliculitis barbae and

Melodie Young discusses the differences in disease presentation between children with PsA and adults with PsA, including differences in symptom onset and disease progression, and

Dr. Oza discusses new methods for detecting preclinical AD in infants, new insights into early-onset AD predictive of future food allergies, and a variety of

Dr. Chovatiya discusses the identification, causes, the variety of manifestations and phenotypes, and treatment approaches for chronic hand eczema.

Dr. Hawkes provides an overview of the difference between chronic and acute urticaria, then further differentiated chronic urticaria as being spontaneous or attributable to a

​Dr. Julie Harper presents a complex case of neurogenic rosacea, a rare subtype characterized primarily by redness, burning, and stinging sensations, rather than the typical

​Dr. Katharina Shaw explores type 1 interferon antagonism as a promising treatment for recalcitrant cutaneous lupus and dermatomyositis, offering new insights into managing these challenging

Dr. Zirwas shares how to best explain environmental triggers of AD to patients who experience disease onset later in life.

Dr. James Del Rosso presents two complex cases—adult female acne tied to PCOS and minocycline-induced symptoms in a rosacea patient—at Maui Derm NP+PA Fall. Topics

Dr. Hawkes discusses the influx of new and emerging oral therapies that have demonstrated success in treating psoriasis.

Dr. Shaw discusses considering domains of disease in patients with PsA, such as possible comorbidities and affected organ systems, before choosing a treatment.

Melodie Young discusses the psychological impact of psoriatic disease on pediatric patients.